Holding(s) in Company

RNS Number : 8080E

Belluscura PLC

31 October 2022

 

31 October 2022

Belluscura PLC

("Belluscura" or the "Company")

Notification of Major Holding

Belluscura PLC (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that the Company has received notification that Tekcapital Plc has reduced its holding from 13.932% to 12.3062% of the total voting rights of the Company.  TekCapital Plc and now holds 15,138,767 Belluscura ordinary shares of 1p each.

The share sale was undertaken on 28 October 2022 by Dowgate Capital who have placed the shares with new and existing shareholders. Tekcapital Plc has undertaken that they will not sell any further shares in Belluscura for a minimum period of six months following the share placing, unless both the Company and Dowgate Capital consent to any such share disposals.

Belluscura plc www.belluscura.com Robert Rauker, Chief Executive Officer via MHP Communications Anthony Dyer, Chief Financial Officer SPARK Advisory Partners Ltd (Nominated Adviser) Tel: [phone] Neil Baldwin Dowgate Capital Ltd (Broker) Tel: [phone] James Serjeant / Nicholas Chambers MHP Communications (Media & Investor Relations) Tel: [phone] or [e-mail] Katie Hunt / Pete Lambie / Matthew Taylor

 

END

 

 

HOLDFLFXLBLZFBL